Caner Ercan
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Liver physiology and pathology
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
- Cancer Genomics and Diagnostics 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Salvatore Piscuoglio (18 shared papers)Mairene Coto‐Llerena (13 shared papers)Gerhard Christofori (3 shared papers)Ravi Kiran Reddy Kalathur (3 shared papers)Ruize Gao (2 shared papers)David Buechel (2 shared papers)Fengyuan Tang (2 shared papers)Fernando D. Camargo (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Nature Communications (2 papers)Cancers (2 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (1 paper)Mucosal Immunology (1 paper)
- Partner nations
- SwitzerlandItalyUnited States
In The Last Decade
Caner Ercan
22 papers receiving 1.0k citations
Caner Ercan's Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 325
- Hepatology 109
- Pulmonary and Respiratory Medicine 311
- Molecular Biology 511
- Oncology 159
Countries citing papers authored by Caner Ercan
This map shows the geographic impact of Caner Ercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caner Ercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caner Ercan more than expected).
Fields of papers citing papers by Caner Ercan
This network shows the impact of papers produced by Caner Ercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caner Ercan. The network helps show where Caner Ercan may publish in the future.
Co-authors
The 25 scholars most cited alongside Caner Ercan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis Hit paper breakdown → | 2021 | 392 |
| 2 | Arginine reprograms metabolism in liver cancer via RBM39 Hit paper breakdown → | 2023 | 191 |
| 3 | 2022 | 97 | |
| 4 | Bipotent transitional liver progenitor cells contribute to liver regeneration Hit paper breakdown → | 2023 | 90 |
| 5 | 2020 | 71 | |
| 6 | 2021 | 49 | |
| 7 | 2021 | 32 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 14 | |
| 11 | 2020 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 11 | |
| 14 | 2024 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2024 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Caner Ercan
Caner Ercan is a scholar working on Cancer Research, Hepatology, Oncology, Molecular Biology and Biotechnology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers), Hepatitis B Virus Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Research and Treatments (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (325 citations), Hepatology (109 citations), Pulmonary and Respiratory Medicine (311 citations), Molecular Biology (511 citations) and Oncology (159 citations). Caner Ercan has collaborated with scholars based in Switzerland, Italy and United States. Frequent co-authors include Salvatore Piscuoglio, Mairene Coto‐Llerena, Gerhard Christofori, Ravi Kiran Reddy Kalathur, Ruize Gao, David Buechel, Fengyuan Tang, Fernando D. Camargo, Shuang Song and Michael T. Dill. Their work appears in journals such as Frontiers in Oncology, Nature Communications, Cancers, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Mucosal Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.